EUVIMEDEUVIMED entdecken
Crossref

Engineered lipid liquid crystalline nanoparticles as an inhaled nanoplatform for mucus penetration enhancement

Wenhao Wang, Jingxuan Zeng, Peili Luo, Jiayi Fang, Qingao Pei, Jinwu Yan, Chune Zhu, Wei Chen, Yanyun Liu, Zhengwei Huang, Ying Huang, Chuanbin Wu und 1 weitere

Drug Delivery and Translational Research · 2023

DOI: 10.1007/s13346-023-01351-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2023. Verfasst von Wenhao Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China. Hauptthemen laut MEDLINE: Drug Carriers, Nanoparticles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation Special Funded Project, Guangzhou Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanocarrier-assisted pulmonary drug delivery system has been widely employed for lung local disease treatment due to its enhanced drug lesion accumulation and reduced systematical side effects. However, the mucus barriers covered on the epithelia of trachea and bronchial tree construct a dense barrier for inhaled nanocarrier transport, which compromises the therapeutical effects. In this study, a lipid liquid crystalline nanoparticle NLP@Z with surface zwitterion material hexadecyl betaine (HB) modification and N-acetylcysteine (NAC) encapsulation was presented to exert the combination strategy of mucus-inert surface and mucus degradation. The HB modification endowed NLP@Z mucus-inert surface to inhibit the interaction between NLP@Z and mucins, and the encapsulated NAC could effectively degrade the mucins and further decrease the mucus viscosity. This combination strategy was proved to significantly promote the mucus penetration performance and enhance epithelial cell uptake. In addition, the proposed NLP@Z was equipped with desired nebulization property, which could be served as a potential pulmonary delivery nanoplatform. In summary, the proposed NLP@Z highlights the employment of the combination strategy for mucus penetration enhancement in pulmonary delivery, which may become a versatile platform for lung disease therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CarriersNanoparticlesMucusMucinsAcetylcysteineLipids

Stichwörter der Autor:innen

Mucus penetrationN-acetylcysteineNebulizationPulmonary deliveryZwitterion material

Substanzen

Drug CarriersMucinsAcetylcysteineLipids

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
  • College of Pharmacy, Jinan University, Guangzhou, 511443, China.
  • MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, China.
  • School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
  • College of Pharmacy, Jinan University, Guangzhou, 511443, China. huangzhengw@jnu.edu.cn.
  • College of Pharmacy, Jinan University, Guangzhou, 511443, China. huangy2007@163.com.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation Special Funded Project
  • Guangzhou Science and Technology Plan Project

Zitieren

APA

Wang, W., Zeng, J., Luo, P., Fang, J., Pei, Q., Yan, J., Zhu, C., Chen, W., Liu, Y., Huang, Z., Huang, Y., Wu, C., & Pan, X. (2023). Engineered lipid liquid crystalline nanoparticles as an inhaled nanoplatform for mucus penetration enhancement. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-023-01351-6

Vancouver

Wang W, Zeng J, Luo P, Fang J, Pei Q, Yan J, et al. Engineered lipid liquid crystalline nanoparticles as an inhaled nanoplatform for mucus penetration enhancement. Drug Delivery and Translational Research. 2023. doi:10.1007/s13346-023-01351-6

BibTeX
@article{Wang2023,
  author = {Wang, Wenhao and Zeng, Jingxuan and Luo, Peili and Fang, Jiayi and Pei, Qingao and Yan, Jinwu and Zhu, Chune and Chen, Wei and Liu, Yanyun and Huang, Zhengwei and Huang, Ying and Wu, Chuanbin and Pan, Xin},
  title = {Engineered lipid liquid crystalline nanoparticles as an inhaled nanoplatform for mucus penetration enhancement},
  journal = {Drug Delivery and Translational Research},
  year = {2023},
  doi = {10.1007/s13346-023-01351-6}
}
Kostenlos starten →